Anti-platelet role of Korean ginseng and ginsenosides in cardiovascular diseases.
J Ginseng Res
; 44(1): 24-32, 2020 Jan.
Article
em En
| MEDLINE
| ID: mdl-32095094
AA, arachidonic acid; AC, adenylyl cyclase; ADP, adenosine diphosphate; ASA, acetylsalicylic acid; ATP, adenosine triphosphate; Akt, protein kinase B; Antiplatelet; COX, cyclooxygenase; CRP, collagen-related peptide; CSF, crude saponin fraction; ERK, extracellular signalregulated kinase; GPVI, glycoprotein VI; Ginsenosides; IC50, half maximal (50%) inhibitory concentration; IP3, inositol-1,4,5-triphosphate; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MKK4, mitogen-activated protein kinase kinase 4; MLC, myosin light chain; Nutraceutical; PAF, platelet-activating factor; PAR, proteinase-activated receptor; PI3K, phosphatidylinositol 3-kinase; PKA, protein kinase A; PKC, protein kinase C; PKG, protein kinase G; PLA2, phospholipase A2; PLCγ2, phospholipase C gamma-2; PPD, protopanaxadiol; PPT, protopanaxatriol; PT, prothrombin time; ROCK, Rho-associated protein kinase; SFK, Src family kinase; Structural modification; Syk, spleen tyrosine kinase; Synergism; TS, total saponin; TxA2, thromboxane A2; TxAS, thromboxane-A synthase; TxB2, thromboxane B2; TxR, thromboxane receptor; VASP, vasodilator-stimulated phosphoprotein; [Ca2+]i, intracellular calcium ion; aPTT, activated partial thromboplastin time; cAMP, cyclic adenosine monophosphate; cPLA2α, cytosolic phospholipase A2α; vWF, von Willebrand factor
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
J Ginseng Res
Ano de publicação:
2020
Tipo de documento:
Article
País de publicação: